You are here: Home » Companies » News
Business Standard

Laurus is ready to flood US with cheap HIV drugs

US patents on key components for some important HIV therapies are set to expire starting in December and Laurus Labs is gearing up to cash in

Ari Altstedter | Bloomberg  |  Mumbai 

Among the coconut plantations and beaches of south India, a factory the size of 35 football fields is preparing to churn out billions of generic pills for HIV patients and flood the US market with the low-cost copycat medicines. US patents on key components for some important HIV therapies are set to expire starting in December and Laurus Labs — the Hyderabad-based company which owns the facility — is gearing up to cash in. Laurus is one of the world’s biggest suppliers of ingredients used in anti-retrovirals, thanks to novel chemistry that delivers cheaper ...

This article is no longer available in our repository.

There could be multiple reasons for this.

First Published: Tue, December 05 2017. 02:32 IST
RECOMMENDED FOR YOU